ArticleFrontiers in immunology2022

Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine.

Sabryna Nantel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.